Skip to main content

Smoking, Cigarette

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Jeil Pharmaceutical
Jeil PharmaceuticalKorea - Seoul
1 program
1
ZeropixPhase 11 trial
Active Trials
NCT03362008Completed31Est. Sep 2017
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Breastfeeding promotionN/A1 trial
Active Trials
NCT04670822Completed60Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Jeil PharmaceuticalZeropix
Human BioSciencesBreastfeeding promotion

Clinical Trials (2)

Total enrollment: 91 patients across 2 trials

Compare the Pharmacokinetic Characteristics and the Safety Between Zeropix and Champix in Healthy Adult Male Subjects.

Start: Jul 2017Est. completion: Sep 201731 patients
Phase 1Completed
NCT04670822Human BioSciencesBreastfeeding promotion

Postpartum Smoking Relapse Prevention by Breastfeeding Promotion

Start: Jul 2018Est. completion: Dec 202360 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.